Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	retinoid binding	UGT1A4 UGT1A3 UGT1A5 RHO	3.72e-06	48	44	4	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A4 UGT1A3 UGT1A5 RHO	4.04e-06	49	44	4	GO:0019840
GeneOntologyMolecularFunction	low voltage-gated calcium channel activity	CACNA1I CACNA1H	1.42e-05	3	44	2	GO:0008332
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A4 UGT1A3 UGT1A5	3.15e-05	28	44	3	GO:0001972
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT1A4 UGT1A3 UGT1A5	6.22e-05	35	44	3	GO:0015020
GeneOntologyMolecularFunction	high voltage-gated calcium channel activity	CACNA1I CACNA1H	4.25e-04	14	44	2	GO:0008331
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A4 UGT1A3 UGT1A5	1.17e-05	21	44	3	GO:0052695
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A4 UGT1A3 UGT1A5	2.28e-05	26	44	3	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A4 UGT1A3 UGT1A5	2.28e-05	26	44	3	GO:0006063
GeneOntologyBiologicalProcess	vitamin D3 metabolic process	UGT1A4 UGT1A3	1.59e-04	9	44	2	GO:0070640
GeneOntologyCellularComponent	rod photoreceptor outer segment	GUCY2F RHO	1.54e-04	9	44	2	GO:0120200
Domain	UDPGT	UGT1A4 UGT1A3 UGT1A5	1.47e-05	21	43	3	PS00375
Domain	UDPGT	UGT1A4 UGT1A3 UGT1A5	1.47e-05	21	43	3	PF00201
Domain	UDP_glucos_trans	UGT1A4 UGT1A3 UGT1A5	1.47e-05	21	43	3	IPR002213
Domain	VDCC_T_a1	CACNA1I CACNA1H	1.55e-05	3	43	2	IPR005445
Domain	VDCCAlpha1	CACNA1I CACNA1H	2.30e-04	10	43	2	IPR002077
Domain	Channel_four-helix_dom	CACNA1I CACNA1H	7.63e-03	57	43	2	IPR027359
Domain	-	CACNA1I CACNA1H	7.63e-03	57	43	2	1.20.120.350
Pathway	REACTOME_ATORVASTATIN_ADME	UGT1A4 UGT1A3 UGT1A5	6.25e-06	15	35	3	MM15697
Pathway	REACTOME_HEME_DEGRADATION	UGT1A4 UGT1A3 UGT1A5	1.55e-05	20	35	3	MM14721
Pathway	REACTOME_PREDNISONE_ADME	UGT1A4 UGT1A3 UGT1A5	2.40e-05	23	35	3	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT1A4 UGT1A3 UGT1A5	2.74e-05	24	35	3	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT1A4 UGT1A3 UGT1A5	3.11e-05	25	35	3	M17787
Pathway	WP_GLUCURONIDATION	UGT1A4 UGT1A3 UGT1A5	3.11e-05	25	35	3	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A4 UGT1A3 UGT1A5	3.11e-05	25	35	3	M605
Pathway	WP_GLUCURONIDATION	UGT1A4 UGT1A3 UGT1A5	3.51e-05	26	35	3	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A4 UGT1A3 UGT1A5	4.40e-05	28	35	3	M19580
Pathway	REACTOME_METABOLISM_OF_PORPHYRINS	UGT1A4 UGT1A3 UGT1A5	6.62e-05	32	35	3	MM14719
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A4 UGT1A3 UGT1A5	1.40e-04	41	35	3	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT1A4 UGT1A3 UGT1A5	1.73e-04	44	35	3	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT1A4 UGT1A3 UGT1A5	1.85e-04	45	35	3	MM15694
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT1A4 UGT1A3 UGT1A5	2.69e-04	51	35	3	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT1A4 UGT1A3 UGT1A5	2.85e-04	52	35	3	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT1A4 UGT1A3 UGT1A5	3.37e-04	55	35	3	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT1A4 UGT1A3 UGT1A5	5.27e-04	64	35	3	M9488
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT1A4 UGT1A3 UGT1A5	6.85e-04	70	35	3	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT1A4 UGT1A3 UGT1A5	7.44e-04	72	35	3	M9257
Pathway	WP_ESTROGEN_METABOLISM	UGT1A3 UGT1A5	1.34e-03	22	35	2	MM15888
Pathway	PID_RHODOPSIN_PATHWAY	GUCY2F RHO	1.47e-03	23	35	2	M204
Pathway	KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1I CACNA1H	1.47e-03	23	35	2	M47666
Pathway	KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL	CACNA1I CACNA1H	1.73e-03	25	35	2	M47948
Pathway	WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT	ABCD3 ATP8B1	2.33e-03	29	35	2	M45551
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A4 UGT1A3 UGT1A5	2.33e-03	107	35	3	MM14595
Pathway	REACTOME_DRUG_ADME	UGT1A4 UGT1A3 UGT1A5	2.46e-03	109	35	3	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A4 UGT1A3 UGT1A5	2.46e-03	109	35	3	M18788
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	UGT1A4 NCOA6	2.66e-03	31	35	2	M39476
Pathway	REACTOME_THE_PHOTOTRANSDUCTION_CASCADE	GUCY2F RHO	2.66e-03	31	35	2	MM14896
Pathway	REACTOME_DRUG_ADME	UGT1A4 UGT1A3 UGT1A5	3.15e-03	119	35	3	MM15692
Pathway	REACTOME_THE_PHOTOTRANSDUCTION_CASCADE	GUCY2F RHO	3.20e-03	34	35	2	M27183
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A4 UGT1A3 UGT1A5	1.69e-07	9	45	3	22511988
Pubmed	A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.	UGT1A4 UGT1A3 UGT1A5	1.69e-07	9	45	3	1339448
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A4 UGT1A3 UGT1A5	2.41e-07	10	45	3	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A4 UGT1A3 UGT1A5	2.41e-07	10	45	3	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A4 UGT1A3 UGT1A5	2.41e-07	10	45	3	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A4 UGT1A3 UGT1A5	2.41e-07	10	45	3	22558097
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A4 UGT1A3 UGT1A5	4.42e-07	12	45	3	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A4 UGT1A3 UGT1A5	4.42e-07	12	45	3	11434514
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A4 UGT1A3 UGT1A5	5.74e-07	13	45	3	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A4 UGT1A3 UGT1A5	5.74e-07	13	45	3	25246029
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A4 UGT1A3 UGT1A5	7.29e-07	14	45	3	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A4 UGT1A3 UGT1A5	7.29e-07	14	45	3	10836148
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A4 UGT1A3 UGT1A5	7.29e-07	14	45	3	14672974
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A4 UGT1A3 UGT1A5	7.29e-07	14	45	3	9295054
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A4 UGT1A3 UGT1A5	1.12e-06	16	45	3	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A4 UGT1A3 UGT1A5	1.36e-06	17	45	3	20639394
Pubmed	A T-type calcium channel required for normal function of a mammalian mechanoreceptor.	CACNA1I CACNA1H	1.64e-06	2	45	2	12808460
Pubmed	Cloning and characterization of cDNAs encoding mouse Ugt1.6 and rabbit UGT1.6: differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin.	UGT1A3 UGT1A5	1.64e-06	2	45	2	8068691
Pubmed	Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.	CACNA1I CACNA1H	1.64e-06	2	45	2	25071191
Pubmed	Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.	UGT1A4 UGT1A3	1.64e-06	2	45	2	24641623
Pubmed	Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes.	CACNA1I CACNA1H	1.64e-06	2	45	2	36786913
Pubmed	N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.	UGT1A4 UGT1A3	1.64e-06	2	45	2	14570768
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A4 UGT1A3 UGT1A5	1.93e-06	19	45	3	23281178
Pubmed	Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.	PUM1 AKAP17A ANAPC1 RRP12 SEC24B	3.83e-06	182	45	5	32239614
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A4 UGT1A3 UGT1A5	4.02e-06	24	45	3	24625756
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1I CACNA1H	4.91e-06	3	45	2	23488970
Pubmed	T-type channels: release a brake, engage a gear.	CACNA1I CACNA1H	4.91e-06	3	45	2	26488564
Pubmed	Differential interactions of Na+ channel toxins with T-type Ca2+ channels.	CACNA1I CACNA1H	4.91e-06	3	45	2	18591418
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1I CACNA1H	4.91e-06	3	45	2	11230107
Pubmed	Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.	CACNA1I CACNA1H	4.91e-06	3	45	2	11897840
Pubmed	Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.	CACNA1I CACNA1H	4.91e-06	3	45	2	28846697
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1I CACNA1H	4.91e-06	3	45	2	33547341
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1I CACNA1H	4.91e-06	3	45	2	28972185
Pubmed	Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey.	UGT1A3 UGT1A5	4.91e-06	3	45	2	12051676
Pubmed	Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.	CACNA1I CACNA1H	4.91e-06	3	45	2	11927664
Pubmed	Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4.	UGT1A4 UGT1A3	4.91e-06	3	45	2	23611809
Pubmed	A role for UDP-glucose glycoprotein glucosyltransferase in expression and quality control of MHC class I molecules.	UGT1A3 UGT1A5	4.91e-06	3	45	2	21383159
Pubmed	Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.	UGT1A3 UGT1A5	9.81e-06	4	45	2	12644700
Pubmed	Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.	UGT1A4 UGT1A3	9.81e-06	4	45	2	9535849
Pubmed	Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.	UGT1A4 UGT1A3	9.81e-06	4	45	2	9271343
Pubmed	Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.	UGT1A4 UGT1A5	9.81e-06	4	45	2	18223459
Pubmed	Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.	CACNA1I CACNA1H	9.81e-06	4	45	2	28165634
Pubmed	Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.	UGT1A4 UGT1A3	1.63e-05	5	45	2	15057901
Pubmed	Isolation of cDNAs for mouse phenol and bilirubin UDP-glucuronosyltransferases and mapping of the mouse gene for phenol UDP-glucuronosyltransferase (Ugtla1) to chromosome 1 by restriction fragment length variations.	UGT1A3 UGT1A5	1.63e-05	5	45	2	7677729
Pubmed	Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.	UGT1A4 UGT1A3	2.45e-05	6	45	2	19204906
Pubmed	Three ways to make a vesicle.	TXNDC5 PUM1 SEC24B	2.58e-05	44	45	3	11252894
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A4 UGT1A5	3.42e-05	7	45	2	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A3 UGT1A5	3.42e-05	7	45	2	8464825
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ABCD3 PRPF19 SMPDL3B TXNDC5 PUM1 POLDIP3 HNRNPH3 RRP12	4.50e-05	1024	45	8	24711643
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT1A4 UGT1A3	4.56e-05	8	45	2	22579593
Pubmed	Evolutionary insights into T-type Ca2+ channel structure, function, and ion selectivity from the Trichoplax adhaerens homologue.	CACNA1I CACNA1H	4.56e-05	8	45	2	28330839
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A4 UGT1A3	4.56e-05	8	45	2	17179145
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A4 UGT1A3	4.56e-05	8	45	2	20610558
Pubmed	Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.	UGT1A4 UGT1A3	4.56e-05	8	45	2	12695355
Pubmed	Neuroepithelial progenitors generate and propagate non-neuronal action potentials across the spinal cord.	CACNA1I CACNA1H	4.56e-05	8	45	2	34478646
Pubmed	Intracellular calcium plays an essential role in cardiac development.	CACNA1I CACNA1H	4.56e-05	8	45	2	12761855
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A4 UGT1A3 UGT1A5	5.64e-05	57	45	3	21886157
Pubmed	International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.	CACNA1I CACNA1H	5.86e-05	9	45	2	16382099
Pubmed	Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.	CACNA1I CACNA1H	7.32e-05	10	45	2	24778262
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MAP3K20 RPF1 PUM1 AKAP17A POLDIP3 HNRNPH3 RRP12	7.43e-05	807	45	7	22681889
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	UGT1A4 UGT1A3 UGT1A5	8.75e-05	66	45	3	19898482
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A4 UGT1A3	1.07e-04	12	45	2	20308471
Pubmed	Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.	UGT1A4 UGT1A3	1.07e-04	12	45	2	18161889
Pubmed	Directed proteomic analysis of the human nucleolus.	RPF1 PRPF19 HNRNPH3 RRP12	1.53e-04	208	45	4	11790298
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ABCD3 PRPF19 NCOA6 SMPDL3B TXNDC5 POLDIP3 HNRNPH3 SEC24B	1.77e-04	1247	45	8	27684187
Pubmed	Secretory protein trafficking and organelle dynamics in living cells.	TXNDC5 PUM1 SEC24B	1.86e-04	85	45	3	11031247
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	ABCD3 PRPF19 TXNDC5 PUM1 POLDIP3 RRP12	1.90e-04	655	45	6	35819319
Pubmed	The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.	PRPF19 HECA HNRNPH3 MAN1B1 RRP12	1.99e-04	417	45	5	36537216
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MAP3K20 ABCD3 PRPF19 PUM1 POLDIP3 HNRNPH3 RRP12 SEC24B	3.07e-04	1353	45	8	29467282
Pubmed	OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.	PRPF19 POLDIP3	3.38e-04	21	45	2	30662561
Pubmed	Functional proteomic analysis of human nucleolus.	RPF1 PRPF19 RRP12	3.56e-04	106	45	3	12429849
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPF1 PRPF19 AKAP17A POLDIP3 HNRNPH3 RRP12	4.18e-04	759	45	6	35915203
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	PRPF19 ANAPC1 RGS3 POLDIP3	4.24e-04	272	45	4	31010829
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ABCD3 PRPF19 TXNDC5 PUM1 ANAPC1 POLDIP3 HNRNPH3 RRP12	4.34e-04	1425	45	8	30948266
Pubmed	Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.	PRPF19 PUM1 HNRNPH3	4.40e-04	114	45	3	31553912
Pubmed	Human transcription factor protein interaction networks.	ABCD3 PRPF19 NCOA6 PUM1 POLDIP3 HNRNPH3 RRP12 SEC24B	4.42e-04	1429	45	8	35140242
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DPYSL5 ABCD3 PRPF19 AKAP17A POLDIP3 HNRNPH3 RRP12	4.47e-04	1082	45	7	38697112
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	ABCD3 PRPF19 AKAP17A POLDIP3 HNRNPH3 RRP12	5.02e-04	786	45	6	29128334
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DPYSL5 MAP3K20 NCOA6 PUM1 PIK3C2B SEC24B	8.09e-04	861	45	6	36931259
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	ABCD3 PRPF19 HNRNPH3 RRP12	8.73e-04	330	45	4	33301849
Pubmed	Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.	ST3GAL2 MAN1B1	1.06e-03	37	45	2	2542563
Pubmed	Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.	ST3GAL2 MAN1B1	1.06e-03	37	45	2	2541446
Pubmed	Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis.	ST3GAL2 MAN1B1	1.12e-03	38	45	2	2829950
Pubmed	Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.	ST3GAL2 MAN1B1	1.12e-03	38	45	2	2187500
Pubmed	Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.	ABCD3 PRPF19 POLDIP3	1.20e-03	161	45	3	36398662
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	PRPF19 PUM1 RRP12	1.22e-03	162	45	3	31363146
Pubmed	Exome sequencing supports a de novo mutational paradigm for schizophrenia.	UGT1A3 SLC26A7	1.24e-03	40	45	2	21822266
Interaction	KDF1 interactions	PUM1 AKAP17A ANAPC1 RRP12 SEC24B	3.74e-05	192	40	5	int:KDF1
Interaction	UGT1A3 interactions	UGT1A3 UGT1A5	3.83e-05	5	40	2	int:UGT1A3
Cytoband	2q37	UGT1A4 UGT1A3 UGT1A5	3.88e-06	31	45	3	2q37
Cytoband	11p15.4	OR52E1 OR52H1 OR52E8	1.01e-03	200	45	3	11p15.4
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A4 UGT1A3 UGT1A5	1.43e-03	226	45	3	chr2q37
GeneFamily	UDP glucuronosyltransferases	UGT1A4 UGT1A3 UGT1A5	2.19e-05	32	31	3	363
GeneFamily	Olfactory receptors, family 52	OR52E1 OR52H1 OR52E8	7.97e-05	49	31	3	165
GeneFamily	Calcium voltage-gated channel subunits	CACNA1I CACNA1H	9.01e-04	26	31	2	253
Coexpression	LANDIS_ERBB2_BREAST_TUMORS_65_DN	UGT1A3 HEPH UGT1A5 ADIPOR2	5.52e-07	41	42	4	MM1093
Drug	almokalant	UGT1A4 UGT1A3 HEPH UGT1A5	4.19e-08	19	43	4	CID003033962
Drug	AC1MRQNQ	UGT1A4 UGT1A3 UGT1A5	5.23e-07	9	43	3	CID003522271
Drug	DHPASiU	UGT1A4 UGT1A3 UGT1A5	5.23e-07	9	43	3	CID000197602
Drug	Chebi:32663	UGT1A4 UGT1A3 UGT1A5	5.23e-07	9	43	3	CID005460873
Drug	3-iodophenol	UGT1A4 UGT1A3 UGT1A5	5.23e-07	9	43	3	CID000012272
Drug	AC1L4J7U	UGT1A4 UGT1A3 UGT1A5	5.23e-07	9	43	3	CID000186631
Drug	4-nitrophenyl)imidazole	UGT1A4 UGT1A3 UGT1A5	1.02e-06	11	43	3	CID000123155
Drug	AC1O5XMV	UGT1A4 UGT1A3 UGT1A5	1.02e-06	11	43	3	CID006442661
Drug	N-OH-DABZ	UGT1A4 UGT1A3 UGT1A5	1.36e-06	12	43	3	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A4 UGT1A3 UGT1A5	1.36e-06	12	43	3	CID000088735
Drug	2,4,6-TCB	UGT1A4 UGT1A3 UGT1A5	1.36e-06	12	43	3	CID000037247
Drug	7,7,7-triphenylheptanoic acid	UGT1A4 UGT1A3 UGT1A5	1.36e-06	12	43	3	CID000276709
Drug	nonanoyl-N-methylglucamide	UGT1A4 UGT1A3 UGT1A5	1.36e-06	12	43	3	CID000160090
Drug	MS-222	UGT1A4 UGT1A3 UGT1A5 RHO	1.42e-06	44	43	4	CID000011400
Drug	tritanol	UGT1A4 UGT1A3 UGT1A5	1.77e-06	13	43	3	CID000006457
Drug	5-azido-UDP-glucuronic acid	UGT1A4 UGT1A3 UGT1A5	1.77e-06	13	43	3	CID003081279
Drug	cotinine-N-glucuronide	UGT1A4 UGT1A3 UGT1A5	1.77e-06	13	43	3	CID000000411
Drug	propranolol glucuronide	UGT1A4 UGT1A3 UGT1A5	2.25e-06	14	43	3	CID000119515
Drug	PCB-61	UGT1A4 UGT1A3 UGT1A5	2.25e-06	14	43	3	CID000036401
Drug	lamotrigine	UGT1A4 UGT1A3 CACNA1I CACNA1H UGT1A5	2.60e-06	116	43	5	CID000003878
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A4 UGT1A3 UGT1A5	2.81e-06	15	43	3	CID000040469
Drug	coumarin-3-carboxylic acid	UGT1A4 UGT1A3 UGT1A5	2.81e-06	15	43	3	CID000010752
Drug	sulforaphane nitrile	UGT1A4 UGT1A3 UGT1A5	2.81e-06	15	43	3	CID000543743
Drug	afloqualone	UGT1A4 UGT1A3 UGT1A5	2.81e-06	15	43	3	CID000002040
Drug	naphthyl sulphate	UGT1A4 UGT1A3 UGT1A5	2.81e-06	15	43	3	CID000114775
Drug	HCG 004	UGT1A4 UGT1A3 UGT1A5 ADIPOR2	3.26e-06	54	43	4	CID000064928
Drug	quercetin-3,4'-diglucoside	UGT1A4 UGT1A3 UGT1A5	3.45e-06	16	43	3	CID005320835
Drug	1'-hydroxyestragole	UGT1A4 UGT1A3 UGT1A5	3.45e-06	16	43	3	CID000040003
Drug	bilirubin-phosphate	UGT1A4 UGT1A3 UGT1A5	3.45e-06	16	43	3	CID005497144
Drug	afloqualone	UGT1A4 UGT1A3	3.48e-06	2	43	2	ctd:C033541
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A4 UGT1A3 UGT1A5	4.19e-06	17	43	3	CID000003573
Drug	6-hydroxychrysene	UGT1A4 UGT1A3 UGT1A5	4.19e-06	17	43	3	CID000037766
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID000152226
Drug	Br 2	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID003060900
Drug	SureCN12722713	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID005488034
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID000036614
Drug	ApApG	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID003081975
Drug	C1 11-32	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID000443077
Drug	C11131	UGT1A4 UGT1A3 UGT1A5	5.02e-06	18	43	3	CID000443076
Drug	9-OH-risperidone	UGT1A4 UGT1A3 UGT1A5	5.95e-06	19	43	3	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A4 UGT1A3 UGT1A5	5.95e-06	19	43	3	CID000091433
Drug	tectochrysin	UGT1A4 UGT1A3 UGT1A5	6.99e-06	20	43	3	CID005281954
Drug	AC1L1OBF	UGT1A4 UGT1A3 UGT1A5	6.99e-06	20	43	3	CID000032736
Drug	4'-hydroxydiclofenac	UGT1A4 UGT1A3 UGT1A5	6.99e-06	20	43	3	CID000116545
Drug	estriol-16-glucuronide	UGT1A4 UGT1A3 UGT1A5	8.15e-06	21	43	3	CID000122281
Drug	dulcin	UGT1A4 UGT1A3 UGT1A5	8.15e-06	21	43	3	CID000009013
Drug	Benzamidoxime hydrochloride	UGT1A4 UGT1A3 UGT1A5	8.15e-06	21	43	3	CID000069186
Drug	amonafide	UGT1A4 UGT1A3 UGT1A5	9.42e-06	22	43	3	CID000050515
Drug	N-methylpiperazine	UGT1A4 UGT1A3 UGT1A5	9.42e-06	22	43	3	CID000053167
Drug	SureCN2398996	CACNA1I CACNA1H	1.04e-05	3	43	2	CID010220069
Drug	N-desmethylmethsuximide	CACNA1I CACNA1H	1.04e-05	3	43	2	CID000092154
Drug	1,3-dioxoisoindoline-5-carboxamide	CACNA1I CACNA1H	1.04e-05	3	43	2	CID010679219
Drug	amidoxime	UGT1A4 UGT1A3 UGT1A5	1.08e-05	23	43	3	CID000465967
Drug	estradiol-3-glucuronide	UGT1A4 UGT1A3 UGT1A5	1.08e-05	23	43	3	CID000066651
Drug	phenanthridine	UGT1A4 UGT1A3 UGT1A5	1.08e-05	23	43	3	CID000009189
Drug	2,2,2-trichloroethanol	UGT1A4 UGT1A3 P2RY4 UGT1A5	1.09e-05	73	43	4	CID000008259
Drug	AS-3201	UGT1A4 UGT1A3 UGT1A5	1.24e-05	24	43	3	CID000153948
Drug	5-MOP	UGT1A4 UGT1A3 UGT1A5	1.40e-05	25	43	3	CID000002355
Drug	AzMC	UGT1A4 UGT1A3 UGT1A5	1.40e-05	25	43	3	CID000064986
Drug	N-acetylbenzidine	UGT1A4 UGT1A3 UGT1A5	1.40e-05	25	43	3	CID000018787
Drug	5,6-benzoquinoline	UGT1A4 UGT1A3 UGT1A5	1.40e-05	25	43	3	CID000006796
Drug	N-phenylmaleimide	UGT1A4 UGT1A3 UGT1A5	1.40e-05	25	43	3	CID000013662
Drug	ciprofibrate	UGT1A4 ABCD3 UGT1A3 NCOA6 UGT1A5	1.67e-05	170	43	5	CID000002763
Drug	DiMeIQx	UGT1A4 UGT1A3 UGT1A5	1.78e-05	27	43	3	CID000104739
Drug	diflunisal	UGT1A4 UGT1A3 UGT1A5	1.78e-05	27	43	3	CID000003059
Drug	phenylbutazone	UGT1A4 UGT1A3 NCOA6 UGT1A5	1.82e-05	83	43	4	CID000004781
Drug	5 alpha-androstane	UGT1A4 UGT1A3 NCOA6 UGT1A5	1.91e-05	84	43	4	CID000094144
Drug	N-hydroxy-4-aminobiphenyl	UGT1A4 UGT1A3 UGT1A5	1.99e-05	28	43	3	CID000081261
Drug	CARMINE	UGT1A4 UGT1A3 UGT1A5	1.99e-05	28	43	3	CID000014749
Drug	erucin	UGT1A4 UGT1A3 UGT1A5	1.99e-05	28	43	3	CID000078160
Drug	H-Ni	UGT1A4 UGT1A3 UGT1A5	1.99e-05	28	43	3	CID000445665
Drug	methsuximide	CACNA1I CACNA1H	2.09e-05	4	43	2	CID000006476
Drug	AC1L1JAL	UGT1A4 UGT1A3 UGT1A5	2.22e-05	29	43	3	CID000004954
Drug	7-hydroxy-4-trifluoromethylcoumarin	UGT1A4 UGT1A3 UGT1A5	2.22e-05	29	43	3	CID005375667
Drug	trans-3'-hydroxycotinine	UGT1A4 UGT1A3 UGT1A5	2.22e-05	29	43	3	CID000000414
Drug	7-hydroxycoumarin glucuronide	UGT1A4 UGT1A3 UGT1A5	2.22e-05	29	43	3	CID000125641
Drug	iberin	UGT1A4 UGT1A3 UGT1A5	2.22e-05	29	43	3	CID000010455
Drug	tolcapone	UGT1A4 UGT1A3 UGT1A5	2.46e-05	30	43	3	CID004659569
Drug	paricalcitol	UGT1A4 UGT1A3 UGT1A5	2.46e-05	30	43	3	CID005281104
Drug	AC1L9E0Q	UGT1A4 UGT1A3 UGT1A5	2.46e-05	30	43	3	CID000443095
Drug	dihydroartemisinin	UGT1A4 UGT1A3 UGT1A5	2.46e-05	30	43	3	CID000107770
Drug	4-ethylphenol	UGT1A4 UGT1A3 UGT1A5	2.72e-05	31	43	3	CID000031242
Drug	PCB 156	UGT1A4 UGT1A3 UGT1A5	2.72e-05	31	43	3	CID000038019
Drug	4'-HPPH	UGT1A4 UGT1A3 UGT1A5	2.72e-05	31	43	3	CID000017732
Drug	indole-2-carboxylic acid	UGT1A4 UGT1A3 UGT1A5	3.00e-05	32	43	3	CID000072899
Drug	NNAL	UGT1A4 UGT1A3 UGT1A5	3.00e-05	32	43	3	CID000104856
Drug	Muracein C	UGT1A4 UGT1A3 UGT1A5	3.00e-05	32	43	3	CID003086323
Drug	TCPOBOP	UGT1A4 UGT1A3 NCOA6 UGT1A5	3.10e-05	95	43	4	CID000005382
Drug	cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A	CACNA1I CACNA1H ST3GAL2 RRP12 HHIPL2	3.24e-05	195	43	5	207_UP
Drug	AC1Q6OQG	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000009686
Drug	R(-)-Denopamine	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000003818
Drug	6-methylsalicylic acid	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000011279
Drug	BP-3,6-quinol	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000119292
Drug	norbuprenorphine	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000114976
Drug	geniposide	UGT1A4 UGT1A3 UGT1A5	3.29e-05	33	43	3	CID000107848
Drug	AC1O7G5C	CACNA1I CACNA1H	3.47e-05	5	43	2	CID006603942
Drug	phensuximide	CACNA1I CACNA1H	3.47e-05	5	43	2	CID000006839
Drug	Flunarizine	CACNA1I CACNA1H	3.47e-05	5	43	2	DB04841
Drug	estragole	UGT1A4 UGT1A3 UGT1A5	3.60e-05	34	43	3	CID000008815
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A	CACNA1I SPAG8 RGS3 POLDIP3 RHO	3.65e-05	200	43	5	2769_UP
Disease	X-11793--oxidized bilirubin measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0021260
Disease	Succinimide measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0022118
Disease	X-24849 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0800909
Disease	X-11530 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0800696
Disease	X-10458 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0800692
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0802740
Disease	X-16946 measurement	UGT1A4 UGT1A3 UGT1A5	1.29e-07	8	40	3	EFO_0800766
Disease	X-11442 measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0021236
Disease	X-11441 measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0801037
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0802127
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0801036
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0004570, GO_0009410
Disease	X-11880 measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A4 UGT1A3 UGT1A5	1.93e-07	9	40	3	EFO_0020691
Disease	X-21448 measurement	UGT1A4 UGT1A3 UGT1A5	2.75e-07	10	40	3	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A4 UGT1A3 UGT1A5	2.75e-07	10	40	3	EFO_0802185
Disease	bilirubin measurement, response to tenofovir	UGT1A4 UGT1A3 UGT1A5	2.75e-07	10	40	3	EFO_0004570, EFO_0009279
Disease	X-23974 measurement	UGT1A4 UGT1A3 UGT1A5	2.75e-07	10	40	3	EFO_0800867
Disease	gallstones	UGT1A4 UGT1A3 ATP8B1 UGT1A5 RRP12	3.56e-07	108	40	5	EFO_0004210
Disease	insomnia, bilirubin measurement	UGT1A4 UGT1A3 UGT1A5	3.78e-07	11	40	3	EFO_0004570, EFO_0004698
Disease	histidine betaine (hercynine) measurement	UGT1A4 UGT1A3 UGT1A5	3.78e-07	11	40	3	EFO_0800972
Disease	aldosterone measurement	UGT1A4 UGT1A3 UGT1A5	3.78e-07	11	40	3	EFO_0010219
Disease	X-21796 measurement	UGT1A4 UGT1A3 UGT1A5	3.78e-07	11	40	3	EFO_0800825
Disease	biliverdin measurement	UGT1A4 UGT1A3 UGT1A5	5.03e-07	12	40	3	EFO_0021033
Disease	p-cresol glucuronide measurement	UGT1A4 UGT1A3 UGT1A5	5.03e-07	12	40	3	EFO_0800079
Disease	retinol dehydrogenase 16 measurement	UGT1A4 UGT1A3 UGT1A5	6.54e-07	13	40	3	EFO_0802007
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A4 UGT1A3 UGT1A5	1.55e-06	17	40	3	EFO_0004611, EFO_0007800
Disease	angiopoietin-related protein 1 measurement	UGT1A4 UGT1A3 UGT1A5	1.86e-06	18	40	3	EFO_0801382
Disease	tissue factor measurement	UGT1A4 UGT1A3 UGT1A5	3.02e-06	21	40	3	EFO_0010623
Disease	cholelithiasis	UGT1A4 UGT1A3 ATP8B1 UGT1A5	6.22e-06	88	40	4	EFO_0004799
Disease	xanthurenate measurement	UGT1A4 UGT1A3 UGT1A5	8.23e-06	29	40	3	EFO_0010551
Disease	response to dolutegravir	UGT1A4 UGT1A3 UGT1A5	9.13e-06	30	40	3	EFO_0600017
Disease	urate measurement, spine bone mineral density	UGT1A4 UGT1A3 UGT1A5	6.76e-05	58	40	3	EFO_0004531, EFO_0007701
Disease	pregnenetriol sulfate measurement	UGT1A4 UGT1A5	9.78e-05	11	40	2	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A4 UGT1A5	9.78e-05	11	40	2	EFO_0600039
Disease	pregnenetriol disulfate measurement	UGT1A4 UGT1A5	1.38e-04	13	40	2	EFO_0800587
Disease	thyroxine measurement	UGT1A4 UGT1A3 UGT1A5	1.97e-04	83	40	3	EFO_0005130
Disease	hormone measurement	UGT1A4 UGT1A3 UGT1A5	2.04e-04	84	40	3	EFO_0004730
Disease	X-21441 measurement	UGT1A4 UGT1A5	2.41e-04	17	40	2	EFO_0800814

Protein segments in the cluster

Peptide	Gene	Start	Entry
MTRAFITHAGSHGVY	UGT1A3	366	P35503
FGIMFDFHSAGIHVL	ATP8B1	1111	O43520
AFTIAHESGHNFGMI	ADAMTS18	431	Q8TE60
VHFHGVSNLQEFRFM	ADIPOR2	361	Q86V24
LGRNGGSMHHLSLFF	RGS3	986	P49796
FRFGENHAIMGVAFT	RHO	146	P08100
GQTGFMHHPSFFTSE	ANAPC1	826	Q9H1A4
SFMTHRFGRNIPHFI	OR52E1	256	Q8NGJ3
MAGGHVFRNAHFDYS	HECA	311	Q9UBI9
AGQFFGHHHTDSFRM	SMPDL3B	271	Q92485
DASSGFHGGHFVHMR	HNRNPH3	186	P31942
MFINTHSGLFTHLGV	MAN1B1	441	Q9UKM7
HMQALHFSFALGAFL	MFSD4B	121	Q5TF39
GHIMEFSQDQHGSRF	PUM1	851	Q14671
TGHMFHIDFGRFLGH	PIK3C2B	1206	O00750
HYVHFSSAVMGLLFG	P2RY4	196	P51582
ASGNHFSGHGMSFNA	NCOA6	841	Q14686
VAFGHHAKFIASTGM	PRPF19	481	Q9UMS4
SRHATFENFGMAFLT	CACNA1I	1656	Q9P0X4
SSFISHHQMASGFIG	GUCY2F	111	P51841
RQLMFHFTSKHHFGF	MT-CO3	221	P00414
DFGASRFHNHTTHMS	MAP3K20	151	Q9NYL2
MHNRSQGFFFSSCHP	KRTAP25-1	1	Q3LHN0
SMVHAGDGTHRFFVA	HHIPL2	221	Q6UWX4
SRHATFSNFGMAFLT	CACNA1H	1786	O95180
GLSMHTFHGNFFVRS	SEC24B	931	O95487
GGIDTSTHFHQTFMN	DPYSL5	61	Q9BPU6
FAASGGFLHHMAGLS	POLDIP3	201	Q9BY77
VLFSIFSMHSGEGRH	OR5F1	221	O95221
FSMHSGEGRHRAFST	OR5F1	226	O95221
GGCLSHMFFIHFFTA	OR52E8	101	Q6IFG1
RFGHNVSRTFHIMFA	OR52H1	271	Q8NGJ2
SFFFRHGHRGLLTMQ	SPAG8	306	Q99932
AFFHGQMLTTRGHHT	HEPH	306	Q9BQS7
GFEQDVGSRTTHHFM	ST3GAL2	186	Q16842
GHIIHIDFGFMFESS	PI4KAP2	456	A4QPH2
HGYHRFMHSVGRVFS	OSM	196	P13725
MQAFHSLFHARPGLS	RRP12	346	Q5JTH9
EHLHNFILFRFSMGF	ABCD3	301	P28288
REEMTGRNFHTFSFG	AKAP17A	196	Q02040
GHSIGRMFASLFPHN	RPF1	256	Q9H9Y2
VQRGHSSMFVFFNGI	SPATA31D1	521	Q6ZQQ2
MTRAFITHAGSHGVY	UGT1A5	366	P35504
MAFNGFASFTRHVRT	ZNF57	231	Q68EA5
AFTSSRAFQGHLRMH	ZNF57	456	Q68EA5
FTHGIQSAAHFVMFF	TXNDC5	71	Q8NBS9
AIFGMGHHVATGTFA	SLC26A7	91	Q8TE54
MTRAFITHAGSHGVY	UGT1A4	366	P22310